Marc Tessier-Lavigne is president of The Rockefeller University, where he is also Carson Family Professor and head of the Laboratory of Brain Development and Repair. He is a pioneer in the study of the molecular signals that direct the formation of neural circuits in the brain during embryonic development. He also studies nerve cell responses to injury and the mechanisms underlying nerve cell death.
Prior to joining Rockefeller, Dr. Tessier-Lavigne served as executive vice president for Research and chief scientific officer at Genentech, a leading biotechnology company.
Dr. Tessier-Lavigne obtained undergraduate degrees from McGill and Oxford Universities and a doctorate degree from University College London (UCL), and was a postdoctoral fellow at UCL and Columbia University. Prior to joining Genentech, he held faculty positions at the University of California, San Francisco and at Stanford University, where he was the Susan B. Ford Professor and an Investigator with the Howard Hughes Medical Institute.
A Rhodes Scholar, Dr. Tessier-Lavigne is the recipient of numerous awards and honors, and he is a member of the National Academy of Sciences and its Institute of Medicine. He is also a member of the corporate Boards of Pfizer Inc., Regeneron Pharmaceuticals, and Agios Pharmaceuticals.